Gain Therapeutics is trading 5.1% lower now at $1.49, with broader biotech weakness providing context; no company-specific catalyst is confirmed.
- XBI was down 2.01% during the regular session.
- Searches found no company announcement for October 13, 2026; the latest official newsroom item was dated October 8.
- Trading volume was not established.